Valuation: Psychemedics Corporation

Market Cap 97.91L 85.56L 78.96L 72.78L 1.37Cr 94Cr 1.4Cr 9.44Cr 3.71Cr 46Cr 3.68Cr 3.6Cr 158.97Cr P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 95.4L 83.37L 76.93L 70.91L 1.34Cr 92Cr 1.37Cr 9.2Cr 3.62Cr 45Cr 3.58Cr 3.5Cr 154.9Cr EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 day+13.18%
1 month+13.18%
3 months+5.96%
6 months+51.83%
Current year+55.62%
1 month 2.49
Extreme 2.49
2.7
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
5.15
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap.
13/12/24
Powell Anderson Capital Partners
BuyCompany 1,59,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

3,20,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
+13.18%-.--%+8.26%-49.29% 1.52Cr
+0.58%-3.71%+82.88%+447.60% 3.86TCr
+0.50%+2.06%+15.20%+33.18% 2.31TCr
+0.64%+2.43%-19.79%-38.73% 752.04Cr
-1.27%-5.69%+8.61%+99.26% 495.32Cr
-2.61%+0.17%+13.04%+43.21% 300.4Cr
+2.90%-8.52%-21.11%+844.64% 183.15Cr
-5.48%+15.20%-9.38%-65.57% 190.8Cr
-1.55%-0.81%+111.43%-15.35% 193.23Cr
-13.79%-0.44%+20.21%-27.31% 191.07Cr
Average -0.69%-2.04%+20.93%+127.16% 848.38Cr
Weighted average by Cap. -0.11%-1.91%+43.43%+232.60%

Financials

2023 2024
Net sales 2.21Cr 1.93Cr 1.78Cr 1.64Cr 3.1Cr 212.81Cr 3.16Cr 21Cr 8.38Cr 104.22Cr 8.3Cr 8.12Cr 358.79Cr 1.97Cr 1.72Cr 1.59Cr 1.46Cr 2.76Cr 189.57Cr 2.82Cr 19Cr 7.46Cr 93Cr 7.39Cr 7.23Cr 319.61Cr
Net income -41.54L -36.3L -33.5L -30.88L -58.2L -40Cr -59.49L -4Cr -1.57Cr -20Cr -1.56Cr -1.53Cr -67Cr -18.61L -16.26L -15.01L -13.83L -26.07L -18Cr -26.65L -1.79Cr -70.55L -8.78Cr -69.89L -68.36L -30Cr
Net Debt 3L 3L 3L 2L 5L 3.22Cr 5L 32.19L 12.66L 1.58Cr 12.54L 12.27L 5.42Cr -3L -2L -2L -2L -4L -2.42Cr -4L -24.19L -10L -1.18Cr -9L -9L -4.08Cr
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock